Reassessing Quality-of-Life Instruments in the Evaluation of New Drugs

被引:0
|
作者
Gordon H. Guyatt
Roman J. Jaeschke
机构
[1] Room 2C12,Department of Clinical Epidemiology and Biostatistics
[2] McMaster University Health Sciences Centre,Department of Medicine
[3] McMaster University,undefined
来源
PharmacoEconomics | 1997年 / 12卷
关键词
Adis International Limited; Health Profile; Utility Measure; Minimal Important Change; Chronic Respiratory Questionnaire;
D O I
暂无
中图分类号
学科分类号
摘要
Investigators use 2 fundamental approaches to the measurement of health-related quality of life (HR-QOL). Generic instruments include health profiles that tap into the full range of HR-QOL issues and are widely applicable, but may lack responsiveness to small but important changes in HR-QOL. Utility measures summarise HR-QOL in a single number between 0 (death) and 1 (full health) and are useful for economic analysis, but may lack responsiveness. Accumulating data suggest the alternatives to generic measures, instruments that are specific to a function or a health problem, are more responsive than generic measures. While direct comparison of the validity and responsiveness of alternative approaches remains limited and should be extended, it is already clear that comprehensive assessment of HR-QOL requires more than 1 type of instrument.
引用
收藏
页码:621 / 626
页数:5
相关论文
共 50 条
  • [41] Towards More Consistent Use of Generic Quality-of-Life Instruments
    Neyt, Mattias
    PHARMACOECONOMICS, 2010, 28 (04) : 345 - 346
  • [42] Towards More Consistent Use of Generic Quality-of-Life Instruments
    Mattias Neyt
    PharmacoEconomics, 2010, 28 : 345 - 346
  • [43] EVALUATION OF QUALITY-OF-LIFE DURING TREATMENT
    BERNHEIM, JL
    BULLETIN DU CANCER, 1986, 73 (05) : 614 - 619
  • [44] Quality-of-life issues in survivors to anaphylactic reactions to drugs
    Baiardini, I.
    Gaeta, F.
    Molinengo, G.
    Braido, F.
    Canonica, G. W.
    Romano, A.
    ALLERGY, 2015, 70 (07) : 877 - 879
  • [45] Quality-of-life measures in the evaluation of antihypertensive drug therapy: Reliability, validity, and quality-of-life domains
    Gandhi, SK
    Kong, SXD
    CLINICAL THERAPEUTICS, 1996, 18 (06) : 1276 - 1295
  • [46] Using quality-of-life instruments to measure outcome after laparoscopic fundoplication
    Bonnet, Gerard
    Khan, Mohammad Imran
    Ong, Lee
    NEW ZEALAND MEDICAL JOURNAL, 2005, 118 (1219) : 34 - 39
  • [47] Content of quality-of-life instruments is affected by item-generation methods
    Rat, Anne-Christine
    Pouchot, Jacques
    Guillemin, Francis
    Baumann, Michele
    Retel-Rude, Nathalie
    Spitz, Elizabeth
    Coste, Joel
    INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2007, 19 (06) : 390 - 398
  • [48] Meaningful change in oncology quality-of-life instruments: a systematic literature review
    Bedard, Gillian
    Zeng, Liang
    Lam, Henry
    Cella, David
    Zhang, Liying
    Lauzon, Natalie
    Chow, Edward
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (04) : 475 - 483
  • [49] Dermatology Life Quality Index used as a standard in validation of 101 quality-of-life instruments: a systematic review
    Vyas, Jui
    Johns, Jeffrey
    Abdelrazik, Yasmina
    Ali, Faraz M.
    Ingram, John R.
    Salek, Sam
    Finlay, Andrew Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I36 - I36
  • [50] Assessing health status and quality-of-life instruments: Attributes and review criteria
    Aaronson, N
    Alonso, J
    Burnam, A
    Lohr, KN
    Patrick, DL
    Perrin, E
    Stein, REK
    QUALITY OF LIFE RESEARCH, 2002, 11 (03) : 193 - 205